The UK government has rejected President Donald Trump's offer to help with the COVID-19 treatment of Prime Minister Boris Johnson.
Johnson was admitted to an intensive-care unit on Monday evening after his "persistent coronavirus symptoms" worsened, a spokesman said.
Following the news, Trump told a press briefing that his administration had contacted Johnson's doctors and told them he had asked two unnamed pharmaceutical companies to offer the prime minister support.
"I've asked two of the leading companies, these are brilliant companies — Ebola, AIDS, others, they've come with the solutions and just have done incredible jobs," Trump said. "And I've asked them to contact London immediately."
He added: "They've really advanced therapeutics and therapeutically and they have arrived in London already. Their London office has whatever they need, and we'll see if we can be of help.
"We've contacted all of Boris's doctors and we'll see what is going to take place, but they are ready to go."
The president did not name the companies or drugs he was referring to, though he has increasingly promoted the antimalarial hydroxychloroquine in combination with the antibiotic azithromycin — drugs whose efficacy treating COVID-19 is being tested but has not been proved.
Johnson's spokesman rejected the offer on Tuesday, saying "any treatment he receives is a matter for his doctors."
"We're confident the prime minister is receiving the best possible care from the National Health Service," the spokesman said. "Any treatment he receives is a matter for his doctors."
"Any treatment he receives is a matter for his doctors," the prime minister's spokesman said Tuesday after President Donald Trump reached out.